Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Fentanyl (nur Darreichungsform LUT), ATC N02AB03, für die Zeit 1.2.2020 – 31.12.2021

World Biggest Tenders Source

This tender with title Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Fentanyl (nur Darreichungsform LUT), ATC N02AB03, für die Zeit 1.2.2020 – 31.12.2021 has been published on Bidding Source portal dated 15 Dec 2019 for the country of Germany. It has been categorized on Pharmaceutical products. For similar tenders you can see tenders mentioned below of this page.

General Information

Germany

Tender Title :

Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Fentanyl (nur Darreichungsform LUT), ATC N02AB03, für die Zeit 1.2.2020 – 31.12.2021

Tender Type :

Contract notice

Reference No. :

2019/S 239-585993

Country :

Germany

Province/City :

Germany-Hamburg

Publish Date :

15 Dec 2019

Closing Date :

5 Nov 2021

Notice Language :

English

Tender Categories (CPVs) :

Pharmaceutical products

Full Tender Details :

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

446354- Germany – Pharmaceutical products – Conclusion of a non-exclusive drug discount agreement pursuant to Section 130a, Paragraph 8 of the Social Code Book V (SGB V) through an open-house model for the active ingredient naproxen/esomeprazole (ATC code according to WHO: M01AE52) Germany 452324- Germany – Pharmaceutical products – Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8 of the Social Code Book V (Open House Model) Germany 454659- Germany – Pharmaceutical products – 1/DLII6/PM030 diverse Arzneimittel Germany 437447- Germany – Pharmaceutical products – Conclusion of a non-exclusive drug discount agreement pursuant to Section 130a, Paragraph 8 of the Social Code Book V (SGB V) by way of an open-house model for the active ingredient safinamide (ATC code according to WHO: N04BD03) Germany 436706-Awarded - Germany – Pharmaceutical products – Announcement of contracts awarded according to §130 a para. 8 SGB V and §130 c SGB V for the active ingredient pasireotide Germany 435831-Awarded - Germany – Pharmaceutical products – Announcement of contracts awarded according to §130 a para. 8 SGB V and §130 c SGB V for the medicinal product Emcitate Germany 430178-Awarded - Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the Social Code Book V for the active ingredient lanreotide, ATC H01CB03 (OBO) for the period November 1, 2024 - October 31, 2025 (plus extension option 1x12 months) Germany 425595-Awarded - Germany – Pharmaceutical products – Award of medicinal products as of 01.07.2025 Germany 410786- Germany – Pharmaceutical products – Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8 SGB V for the active ingredients mentioned with the option of concluding the agreement within the framework of the so-called open house procedure. Germany 409776- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 or 130c Paragraph 1 SGB V for the period from 01.08.2025 to 31.07.2027 Germany

Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Fentanyl (nur Darreichungsform LUT), ATC N02AB03, für die Zeit 1.2.2020 – 31.12.2021

General Information

Germany

Similar Tenders

Pharmaceutical products Tenders

Germany Tenders

Europe Tenders

Tenders

info@biddingsource.com